Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 08, 2018 Filed Jun 13, 2018 00:26 UTC |
Neville Robert NDirector · Chief Executive Officer
|
SaleCommon Stock | 2,737 | $12.13 | $33,212.13 |
DisclosureSEC source: 0000899243-18-016286 · doc4.xml · nonDerivative · entry 1 Neville Robert N · CIK 0001703487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 402,648 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2017. F2 · price: The price is a weighted average sale price. The sale prices ranged from $12.00 to $12.57. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 08, 2018 Filed Jun 13, 2018 00:26 UTC |
Lowrance David LChief Financial Officer
|
SaleCommon Stock | 675 | $12.13 | $8,186.60 |
DisclosureSEC source: 0000899243-18-016285 · doc4.xml · nonDerivative · entry 1 Lowrance David L · CIK 0001408498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,080 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2017. F2 · price: The price is a weighted average sale price. The sale prices ranged from $12.00 to $12.40. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 08, 2018 Filed Jun 13, 2018 00:22 UTC |
Jouhikainen Jaakko TaneliSee Remarks
|
SaleCommon Stock | 2,638 | $12.11 | $31,949.61 |
DisclosureSEC source: 0000899243-18-016282 · doc4.xml · nonDerivative · entry 1 Jouhikainen Jaakko Taneli · CIK 0001703641 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,688 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2017. F2 · price: The price is a weighted average sale price. The sale prices ranged from $12.00 to $12.55. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 12:01 UTC |
PIKOVER YURIDirector
|
PurchaseCommon Stock | 3,734 | $9.00 | $33,603.01 |
DisclosureSEC source: 0000899243-18-009018 · doc4.xml · nonDerivative · entry 1 PIKOVER YURI · CIK 0001032389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,734 F1 · price: The price is a weighted average purchase price. The purchase prices ranged from $8.98 to $9.00. The purchase prices ranged from $8.98 to $9.00. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 11:09 UTC |
Neville Robert NDirector · Chief Executive Officer
|
SaleCommon Stock | 9,476 | $13.08 | $123,916.70 |
DisclosureSEC source: 0000899243-18-004482 · doc4.xml · nonDerivative · entry 2 Neville Robert N · CIK 0001703487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 405,385 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2017. F3 · price: The price reported is a weighted average sale price. The sale prices ranged from $13.00 to $13.71 per share. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 11:09 UTC |
Neville Robert NDirector · Chief Executive Officer
|
SaleCommon Stock | 15,524 | $12.84 | $199,256.75 |
DisclosureSEC source: 0000899243-18-004482 · doc4.xml · nonDerivative · entry 1 Neville Robert N · CIK 0001703487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 414,861 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2017. F2 · price: The price reported is a weighted average sale price. The sale prices ranged from $12.21 to $12.99 per share. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 11:08 UTC |
Jouhikainen Jaakko TaneliSee Remarks
|
SaleCommon Stock | 8,890 | $13.05 | $115,981.61 |
DisclosureSEC source: 0000899243-18-004481 · doc4.xml · nonDerivative · entry 2 Jouhikainen Jaakko Taneli · CIK 0001703641 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,326 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2017. F3 · price: The price reported is a weighted average sale price. The sale prices ranged from $13.00 to $13.71 per share. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 11:08 UTC |
Jouhikainen Jaakko TaneliSee Remarks
|
SaleCommon Stock | 16,110 | $12.75 | $205,338.06 |
DisclosureSEC source: 0000899243-18-004481 · doc4.xml · nonDerivative · entry 1 Jouhikainen Jaakko Taneli · CIK 0001703641 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,216 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2017. F2 · price: The price reported is a weighted average sale price. The sale prices ranged from $12.21 to $12.99 per share. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 11:07 UTC |
Lowrance David LChief Financial Officer
|
SaleCommon Stock | 2,064 | $13.30 | $27,442.74 |
DisclosureSEC source: 0000899243-18-004480 · doc4.xml · nonDerivative · entry 4 Lowrance David L · CIK 0001408498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,755 F1 · shares: The sales reported on this Form 4 for February 15, 2018 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2017. F3 · price: The price reported is a weighted average sale price. The sale prices ranged from $13.00 to $13.71. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 11:07 UTC |
Lowrance David LChief Financial Officer
|
SaleCommon Stock | 4,936 | $12.70 | $62,686.71 |
DisclosureSEC source: 0000899243-18-004480 · doc4.xml · nonDerivative · entry 3 Lowrance David L · CIK 0001408498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,819 F1 · shares: The sales reported on this Form 4 for February 15, 2018 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2017. F2 · price: The price reported is a weighted average sale price. The sale prices ranged from $12.31 to $12.96. Read SEC document |
| January 02, 2018 Filed Feb 20, 2018 11:07 UTC |
Lowrance David LChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 31,894 | $0.00 Strike: $1.51 | $0.00 |
DisclosureSEC source: 0000899243-18-004480 · doc4.xml · derivative · entry 5 Lowrance David L · CIK 0001408498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,684 Underlying: Common Stock · 31,894 shares Expires 2026-10-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option vest and become exercisable in sixteen equal quarterly installments beginning on February 1, 2017. Read SEC document |
| January 02, 2018 Filed Feb 20, 2018 11:07 UTC |
Lowrance David LChief Financial Officer
|
Tax withholdingCommon Stock | 3,239 | $15.06 | $48,779.34 |
DisclosureSEC source: 0000899243-18-004480 · doc4.xml · nonDerivative · entry 2 Lowrance David L · CIK 0001408498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,755 Read SEC document |
| January 02, 2018 Filed Feb 20, 2018 11:07 UTC |
Lowrance David LChief Financial Officer
|
Exercise / conversionCommon Stock | 31,894 | $1.51 | $48,159.94 |
DisclosureSEC source: 0000899243-18-004480 · doc4.xml · nonDerivative · entry 1 Lowrance David L · CIK 0001408498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,994 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 17, 2017 Filed Dec 19, 2017 18:49 UTC |
PIKOVER YURIDirector
|
GrantStock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $15.21 | $0.00 |
DisclosureSEC source: 0000899243-17-029234 · doc4.xml · derivative · entry 1 PIKOVER YURI · CIK 0001032389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 3,750 shares Expires 2027-12-17 F1 · derivative.exercise_date: The option vests and becomes exercisable in six equal monthly installments on each monthly anniversary of December 17, 2017, subject to the reporting person's continued service with the Issuer. Read SEC document |
| December 17, 2017 Filed Dec 20, 2017 00:02 UTC |
Elam Nevan CDirector
|
GrantStock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $15.21 | $0.00 |
DisclosureSEC source: 0000899243-17-029246 · doc4.xml · derivative · entry 1 Elam Nevan C · CIK 0001314773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 3,750 shares Expires 2027-12-17 F1 · derivative.exercise_date: The option vests and becomes exercisable in six equal monthly installments on each monthly anniversary of December 17, 2017, subject to the reporting person's continued service with the Issuer. Read SEC document |
| December 17, 2017 Filed Dec 20, 2017 00:01 UTC |
McCracken Joseph SDirector
|
GrantStock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $15.21 | $0.00 |
DisclosureSEC source: 0000899243-17-029244 · doc4.xml · derivative · entry 1 McCracken Joseph S · CIK 0001632454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 3,750 shares Expires 2027-12-17 F1 · derivative.exercise_date: The option vests and becomes exercisable in six equal monthly installments on each monthly anniversary of December 17, 2017, subject to the reporting person's continued service with the Issuer. Read SEC document |
| December 17, 2017 Filed Dec 19, 2017 23:47 UTC |
Hawkins Richard JDirector
|
GrantStock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $15.21 | $0.00 |
DisclosureSEC source: 0000899243-17-029233 · doc4.xml · derivative · entry 1 Hawkins Richard J · CIK 0001307632 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 3,750 shares Expires 2027-12-17 F1 · derivative.exercise_date: The option vests and becomes exercisable in six equal monthly installments on each monthly anniversary of December 17, 2017, subject to the reporting person's continued service with the Issuer. Read SEC document |
| October 27, 2017 Filed Oct 27, 2017 16:04 UTC |
PIKOVER YURIDirector
|
PurchaseCommon Stock | 50,000 | $7.85 | $392,500.00 |
DisclosureSEC source: 0000899243-17-024810 · doc4.xml · nonDerivative · entry 1 PIKOVER YURI · CIK 0001032389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Read SEC document |
| June 07, 2017 Filed Jun 9, 2017 10:34 UTC |
PIKOVER YURIDirector
|
PurchaseCommon Stock | 100,000 | $4.75 | $475,000.00 |
DisclosureSEC source: 0000899243-17-015872 · doc4.xml · nonDerivative · entry 1 PIKOVER YURI · CIK 0001032389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Read SEC document |
| June 07, 2017 Filed Jun 9, 2017 14:38 UTC |
Neville Robert NDirector · Chief Executive Officer
|
PurchaseCommon Stock | 52,250 | $4.75 | $248,187.50 |
DisclosureSEC source: 0000899243-17-015876 · doc4.xml · nonDerivative · entry 1 Neville Robert N · CIK 0001703487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 430,385 Read SEC document |
| June 07, 2017 Filed Jun 9, 2017 14:35 UTC |
RAMSAY DAVID ADirector
|
PurchaseCommon Stock | 21,000 | $4.75 | $99,750.00 |
DisclosureSEC source: 0000899243-17-015874 · doc4.xml · nonDerivative · entry 1 RAMSAY DAVID A · CIK 0001283292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,428 Read SEC document |
| June 07, 2017 Filed Jun 9, 2017 14:34 UTC |
Jouhikainen Jaakko TaneliSee Remarks
|
PurchaseCommon Stock | 10,500 | $4.75 | $49,875.00 |
DisclosureSEC source: 0000899243-17-015871 · doc4.xml · nonDerivative · entry 1 Jouhikainen Jaakko Taneli · CIK 0001703641 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,326 Read SEC document |
| June 07, 2017 Filed Jun 9, 2017 14:31 UTC |
Lowrance David LChief Financial Officer
|
PurchaseCommon Stock | 2,100 | $4.75 | $9,975.00 |
DisclosureSEC source: 0000899243-17-015869 · doc4.xml · nonDerivative · entry 1 Lowrance David L · CIK 0001408498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,100 Read SEC document |
| June 07, 2017 Filed Jun 9, 2017 14:30 UTC |
McCracken Joseph SDirector
|
PurchaseCommon Stock | 52,250 | $4.75 | $248,187.50 |
DisclosureSEC source: 0000899243-17-015868 · doc4.xml · nonDerivative · entry 1 McCracken Joseph S · CIK 0001632454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,866 Read SEC document |
| May 25, 2017 Filed May 26, 2017 22:53 UTC |
RAMSAY DAVID ADirector
|
GrantStock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $5.13 | $0.00 |
DisclosureSEC source: 0000899243-17-014622 · doc4.xml · derivative · entry 1 RAMSAY DAVID A · CIK 0001283292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 3,750 shares Expires 2027-05-25 F1 · derivative.exercise_date: The option vests and becomes exercisable in six equal monthly installments on each monthly anniversary of May 25, 2017, subject to the reporting person's continued service with the Issuer. Read SEC document |
| May 25, 2017 Filed May 26, 2017 22:45 UTC |
Pauls MatthewDirector
|
GrantStock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $5.13 | $0.00 |
DisclosureSEC source: 0000899243-17-014620 · doc4.xml · derivative · entry 1 Pauls Matthew · CIK 0001573429 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 3,750 shares Expires 2027-05-25 F1 · derivative.exercise_date: The option vests and becomes exercisable in six equal monthly installments on each monthly anniversary of May 25, 2017, subject to the reporting person's continued service with the Issuer. Read SEC document |
| April 27, 2017 Filed Jun 19, 2019 21:58 UTC |
RAMSAY DAVID ADirector
|
Exercise / conversionRestricted Stock Units · Derivative | 1,142 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-017457 · doc4.xml · derivative · entry 7 RAMSAY DAVID A · CIK 0001283292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,142 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: The vesting of the restricted stock units occurred upon April 27, 2017 upon the consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among Mast Therapeutics, Inc., Savara Inc., and Victoria Merger Corp. (the "Merger Agreement") but due to an administrative error was not reported at that time, and the shares were omitted from subsequent Form 4 filings. F2 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The amount reported reflects the 70-for-one reverse stock split implemented by the issuer on April 27, 2017. F3 · derivative.exercise_date: The restricted stock units vested in full on April 27, 2017, upon consummation of the merger transaction contemplated by the Merger Agreement. F3 · derivative.expiration_date: The restricted stock units vested in full on April 27, 2017, upon consummation of the merger transaction contemplated by the Merger Agreement. Read SEC document |
| April 27, 2017 Filed Jun 19, 2019 21:58 UTC |
RAMSAY DAVID ADirector
|
Exercise / conversionCommon Stock | 1,142 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-017457 · doc4.xml · nonDerivative · entry 1 RAMSAY DAVID A · CIK 0001283292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,570 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: The vesting of the restricted stock units occurred upon April 27, 2017 upon the consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among Mast Therapeutics, Inc., Savara Inc., and Victoria Merger Corp. (the "Merger Agreement") but due to an administrative error was not reported at that time, and the shares were omitted from subsequent Form 4 filings. Read SEC document |
| April 27, 2017 Filed Sep 16, 2020 01:45 UTC |
Pauls MatthewDirector · See Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 650 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-025225 · doc4.xml · derivative · entry 3 Pauls Matthew · CIK 0001573429 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 650 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: The vesting of the restricted stock units ("RSUs") occurred upon April 27, 2017 upon the consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among Mast Therapeutics, Inc., Savara Inc., and Victoria Merger Corp. (the "Merger Agreement") but due to an administrative error was not reported at that time, and the shares were omitted from subsequent Form 4 filings. F3 · shares: Each RSU represents a contingent right to receive one share of the issuer's common stock. The amount reported reflects the 70-for-one reverse stock split implemented by the issuer on April 27, 2017. F4 · derivative.exercise_date: The restricted stock units vested in full on April 27, 2017, upon consummation of the merger transaction contemplated by the Merger Agreement. F4 · derivative.expiration_date: The restricted stock units vested in full on April 27, 2017, upon consummation of the merger transaction contemplated by the Merger Agreement. Read SEC document |
| April 27, 2017 Filed Sep 16, 2020 01:45 UTC |
Pauls MatthewDirector · See Remarks
|
Exercise / conversionCommon Stock | 650 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-025225 · doc4.xml · nonDerivative · entry 1 Pauls Matthew · CIK 0001573429 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: The vesting of the restricted stock units ("RSUs") occurred upon April 27, 2017 upon the consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among Mast Therapeutics, Inc., Savara Inc., and Victoria Merger Corp. (the "Merger Agreement") but due to an administrative error was not reported at that time, and the shares were omitted from subsequent Form 4 filings. Read SEC document |
| January 23, 2017 Filed Jan 23, 2017 22:16 UTC |
Pauls MatthewDirector
|
GrantRestricted Stock Units · Derivative | 45,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-005127 · doc4.xml · derivative · entry 1 Pauls Matthew · CIK 0001573429 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,535 Underlying: Common Stock · 45,535 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017). F2 · derivative.expiration_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017). Read SEC document |
| January 20, 2017 Filed Jan 23, 2017 17:12 UTC |
DITTRICH HOWARDDirector
|
GrantRestricted Stock Units · Derivative | 63,933 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-005121 · doc4.xml · derivative · entry 1 DITTRICH HOWARD · CIK 0001065156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,933 Underlying: Common Stock · 63,933 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017). F2 · derivative.expiration_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017). Read SEC document |
| January 20, 2017 Filed Jan 23, 2017 22:09 UTC |
Roberts BrandiChief Financial Officer & SVP
|
GrantRestricted Stock Units · Derivative | 889,926 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-005113 · doc4.xml · derivative · entry 1 Roberts Brandi · CIK 0001516354 · Chief Financial Officer & SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 889,926 Underlying: Common Stock · 889,926 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017). F2 · derivative.expiration_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017). Read SEC document |
| January 20, 2017 Filed Jan 23, 2017 22:23 UTC |
Greenleaf PeterDirector
|
GrantRestricted Stock Units · Derivative | 45,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-005145 · doc4.xml · derivative · entry 1 Greenleaf Peter · CIK 0001363683 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,535 Underlying: Common Stock · 45,535 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017). F2 · derivative.expiration_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017). Read SEC document |
| January 20, 2017 Filed Jan 23, 2017 22:22 UTC |
RAMSAY DAVID ADirector
|
GrantRestricted Stock Units · Derivative | 79,962 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-005139 · doc4.xml · derivative · entry 1 RAMSAY DAVID A · CIK 0001283292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,962 Underlying: Common Stock · 79,962 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017). F2 · derivative.expiration_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017). Read SEC document |
| January 20, 2017 Filed Jan 23, 2017 22:20 UTC |
Hood ShanaGeneral Counsel & VP
|
GrantRestricted Stock Units · Derivative | 453,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-005134 · doc4.xml · derivative · entry 1 Hood Shana · CIK 0001663796 · General Counsel & VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 453,556 Underlying: Common Stock · 453,556 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017). F2 · derivative.expiration_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017). Read SEC document |
| January 20, 2017 Filed Jan 23, 2017 22:18 UTC |
Culley Brian MDirector · CEO and Director
|
GrantRestricted Stock Units · Derivative | 2,368,194 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-005130 · doc4.xml · derivative · entry 1 Culley Brian M · CIK 0001310683 · Director · CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,368,194 Underlying: Common Stock · 2,368,194 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017). F2 · derivative.expiration_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017). Read SEC document |
| January 20, 2017 Filed Jan 23, 2017 22:14 UTC |
Parsley Edwin L.Chief Medical Officer & SVP
|
GrantRestricted Stock Units · Derivative | 894,572 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-005125 · doc4.xml · derivative · entry 1 Parsley Edwin L. · CIK 0001600117 · Chief Medical Officer & SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 894,572 Underlying: Common Stock · 894,572 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017). F2 · derivative.expiration_date: The restricted stock units vest in full upon consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among the issuer, Savara Inc., and Victoria Merger Corp. (provided such event occurs on or before July 6, 2017). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.